Sermorelin is a synthetic Growth Hormone–Releasing Hormone (GHRH) analogue used in research to stimulate endogenous growth hormone (GH) secretion and support studies on metabolic function, body composition, and tissue repair.
$69.00
For laboratory research use only. Not for human or animal use or consumption. Not a drug, food, dietary supplement, or cosmetic. Not approved by the FDA for any medical use.
Sermorelin (GRF 1–29) is a synthetic peptide fragment of naturally occurring Growth Hormone–Releasing Hormone (GHRH). It acts on the pituitary gland to increase endogenous GH secretion in a physiologic, pulsatile pattern, making it a valuable tool in research on growth hormone dynamics, metabolism, and tissue regeneration.
Stimulates pituitary somatotroph cells to release GH
Supports cellular repair, metabolic regulation, and lean body composition
Mimics natural GH release cycles, particularly during deep sleep
General Dose: 400 mcg, typically administered at night to align with GH peaks
Cycle Length: 8–10 weeks, with recommended off-cycle of 4–8 weeks
Administration Notes: Best taken 30 minutes before eating or 2 hours after, as carbs and fat can blunt GH release
Designed for research purposes only; not for human or animal consumption
Effects may vary depending on experimental conditions and subject response
Used in combination studies with GHRPs (e.g., Ipamorelin, GHRP-2/6) to evaluate synergistic GH release
Class: Growth Hormone–Releasing Hormone (GHRH) analogue
Primary Research Focus: Endogenous GH stimulation, metabolic regulation, tissue repair, body composition studies
Reviews
There are no reviews yet.